The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*
Abstract
BACKGROUND: Mycophenolate mofetil, a pro-drug for mycophenolic acid, reduces the likelihood of allograft rejection after renal transplantation. We studied the relationship between mycophenolic acid pharmacokinetics and the likelihood of rejection in a randomized concentration-controlled trial. METHODS: Under double-blind conditions, recipients of kidney transplants were followed for evidence of allograft rejection for 6 months. In addition to mycophenolate mofetil, patients received usual doses of cyclosporine (INN, ciclosporin) and corticosteroids. The dose of mycophenolate mofetil (given twice daily) was controlled by feedback, with mycophenolic acid area under the concentration-time curve (AUC) as the controlled variable. Patients were randomly assigned to 1 of 3 target AUC groups. RESULTS: Logistic regression analysis showed a significant (P < .0001) relationship between mycophenolic acid AUC and the likelihood of rejection. High mycophenolic acid values were associated with a very low probability of rejection. An AUC of 15 micrograms.h/mL yielded 50% of maximal achievable efficacy with a 4% change of efficacy for a 1 microgram.h/mL change in AUC at the midpoint of the logistic curve. Exploratory analyses showed other variables (e.g., the maximum observed plasma concentration, predose plasma concentration, and drug dose) had poorer predictive power for the rejection outcome. Bivariate regression confirmed the importance of AUC as a highly predictive variable and showed low predictive value of other variables, once the contribution of AUC had been considered. The characteristic side effects of mycophenolate mofetil therapy appeared related to drug dose but not to mycophenolic acid concentration. CONCLUSIONS: The AUC of mycophenolic acid is predictive of the likelihood of allograft rejection after renal transplantation in patients receiving mycophenolate mofetil.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solez, K., Axelsen, R. A., Benediktsson, H., Burdick, J. F., Cohen, A. H., Colvin, R. B., Croker, B. P., Droz, D., Dunnill, M. S., Halloran, P. F., et al. (1993) · Kidney International · doi:10.1038/ki.1993.259 · Cited by 1,424
SOLLINGER, H. W. (1995) · Transplantation · doi:10.1097/00007890-199508000-00003 · Cited by 1,363
(1996) · Transplantation · doi:10.1097/00007890-199604150-00008 · Cited by 1,055
Grinyo, J. M., GROTH, C. G., Pichlmayr, R., Sadek, S., Vanrenterghem, Y. F. C., Behrend, M., Luck, R. P., Moreso, F., Peeters, J. A. G., Rodicio, J. L., et al. (1995) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 974
Self-citationEuropean Mycophenolate Mofetil Cooperative Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92534-1 · Cited by 927
The randomized concentration-controlled trial: An evaluation of its sample size efficiency
Sanathanan, L. P., & Peck, C. C. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90041-j · Cited by 87
Cited by
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Pharmacokinetic/Pharmacodynamic Modeling in Drug Development
Sheiner, L. B., & Steimer, J.-L. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.67 · Cited by 351
Adverse Gastrointestinal Effects of Mycophenolate Mofetil: Aetiology, Incidence and Management
Behrend, M. (2001) · Drug Safety · doi:10.2165/00002018-200124090-00002 · Cited by 322
van Gelder, T., Silva, H. T., de Fijter, J. W., Budde, K., Kuypers, D., Tyden, G., Lohmus, A., Sommerer, C., Hartmann, A., Le Meur, Y., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e318186f98a · Cited by 284
Metadata
- Authors
- Hale, M. D., Nicholls, A. J., Bullingham, R. E. S., Hené, R., Hoitsma, A., Squifflet, J.-P., Weimar, W., Vanrenterghem, Y., Van de Woude, F. J., & Verpooten, G. A.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1998-12
- Volume
- 64
- Issue
- 6
- Pages
- 672-683
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1981535286
- Cited by
- 399
- References
- 6
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*. https://app.cochat.ai/papers/10.1016/s0009-9236(98)90058-3
- The paper
- Hale, M. D., Nicholls, A. J., Bullingham, R. E. S., Hené, R., Hoitsma, A., Squifflet, J.-P., Weimar, W., Vanrenterghem, Y., Van de Woude, F. J., & Verpooten, G. A. (1998). The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(98)90058-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.